Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal CancerFausto Petrelli, Alberto F. Sobrero, Roberto Labianca et al.|JAMA Oncology|2020Cited by 49
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trialGerardo Rosati, Giordano Beretta, Maria Banzi et al.|European Journal of Cancer|2021Cited by 15
399O Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in elderly patients: A subgroup analysis from TOSCA trialGerardo Rosati, Roberto Labianca, Francesca Galli et al.|Annals of Oncology|2020Cited by 5